116 related articles for article (PubMed ID: 33766769)
1. Exploring naltrexamine derivatives featuring azaindole moiety via nitrogen-walk approach to investigate their in vitro pharmacological profiles at the mu opioid receptor.
Ma H; Wang H; Gillespie JC; Mendez RE; Selley DE; Zhang Y
Bioorg Med Chem Lett; 2021 Jun; 41():127953. PubMed ID: 33766769
[TBL] [Abstract][Full Text] [Related]
2. Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists.
Zaidi SA; Arnatt CK; He H; Selley DE; Mosier PD; Kellogg GE; Zhang Y
Bioorg Med Chem; 2013 Nov; 21(21):6405-13. PubMed ID: 24055076
[TBL] [Abstract][Full Text] [Related]
3. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.
Wang H; Reinecke BA; Zhang Y
J Comput Aided Mol Des; 2020 Aug; 34(8):879-895. PubMed ID: 32193867
[TBL] [Abstract][Full Text] [Related]
4. Methylation Products of 6β- N-Heterocyclic Substituted Naltrexamine Derivatives as Potential Peripheral Opioid Receptor Modulators.
Zheng Y; Obeng S; Wang H; Stevens DL; Komla E; Selley DE; Dewey WL; Akbarali HI; Zhang Y
ACS Chem Neurosci; 2018 Dec; 9(12):3028-3037. PubMed ID: 30001114
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
Peng X; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2007 May; 50(9):2254-8. PubMed ID: 17407276
[TBL] [Abstract][Full Text] [Related]
6. Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines.
Cami-Kobeci G; Neal AP; Bradbury FA; Purington LC; Aceto MD; Harris LS; Lewis JW; Traynor JR; Husbands SM
J Med Chem; 2009 Mar; 52(6):1546-52. PubMed ID: 19253970
[TBL] [Abstract][Full Text] [Related]
7. Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.
Yuan Y; Li G; He H; Stevens DL; Kozak P; Scoggins KL; Mitra P; Gerk PM; Selley DE; Dewey WL; Zhang Y
ACS Chem Neurosci; 2011 Jul; 2(7):346-51. PubMed ID: 22816021
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.
Li G; Low PS
Bioorg Med Chem Lett; 2017 May; 27(9):2074-2078. PubMed ID: 28291693
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
[TBL] [Abstract][Full Text] [Related]
11. 6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand.
Williams DA; Zheng Y; David BG; Yuan Y; Zaidi SA; Stevens DL; Scoggins KL; Selley DE; Dewey WL; Akbarali HI; Zhang Y
ACS Chem Neurosci; 2016 Aug; 7(8):1120-9. PubMed ID: 27269866
[TBL] [Abstract][Full Text] [Related]
12. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Wang D; Sun X; Sadee W
J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues.
Sayre LM; Larson DL; Takemori AE; Portoghese PS
J Med Chem; 1984 Oct; 27(10):1325-35. PubMed ID: 6090663
[TBL] [Abstract][Full Text] [Related]
14. Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation.
Wang H; Zaidi SA; Zhang Y
Bioorg Med Chem; 2017 Apr; 25(8):2463-2471. PubMed ID: 28302509
[TBL] [Abstract][Full Text] [Related]
15. 'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.
Weltrowska G; Lemieux C; Chung NN; Guo JJ; Wilkes BC; Schiller PW
Bioorg Med Chem; 2014 Sep; 22(17):4581-6. PubMed ID: 25129170
[TBL] [Abstract][Full Text] [Related]
16. Ethanol and Naltrexone Have Distinct Effects on the Lateral Nano-organization of Mu and Kappa Opioid Receptors in the Plasma Membrane.
Tobin SJ; Wakefield DL; Terenius L; Vukojević V; Jovanović-Talisman T
ACS Chem Neurosci; 2019 Jan; 10(1):667-676. PubMed ID: 30418735
[TBL] [Abstract][Full Text] [Related]
17. Reporter affinity labels: an o-phthalaldehyde derivative of beta-naltrexamine as a fluorogenic ligand for opioid receptors.
Le Bourdonnec B; El Kouhen R; Lunzer MM; Law PY; Loh HH; Portoghese PS
J Med Chem; 2000 Jun; 43(13):2489-92. PubMed ID: 10891107
[No Abstract] [Full Text] [Related]
18. Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure.
Birdsong WT; Arttamangkul S; Clark MJ; Cheng K; Rice KC; Traynor JR; Williams JT
J Neurosci; 2013 Feb; 33(9):4118-27. PubMed ID: 23447620
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.
Zhang Y; Elbegdorj O; Yuan Y; Beletskaya IO; Selley DE
Bioorg Med Chem Lett; 2013 Jul; 23(13):3719-22. PubMed ID: 23721804
[TBL] [Abstract][Full Text] [Related]
20. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.
Fang X; Larson DL; Portoghese PS
J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
